PD45-04 OUTCOMES OF GENITOURINARY MALIGNANCY IN SOLID ORGAN TRANSPLANT RECIPIENTS

You have accessJournal of UrologyRenal Transplantation & Vascular Surgery II (PD45)1 Sep 2021PD45-04 OUTCOMES OF GENITOURINARY MALIGNANCY IN SOLID ORGAN TRANSPLANT RECIPIENTS Song Jiang, Brent Cleveland, and Christopher Warlick JiangSong Jiang More articles by this author , ClevelandBrent Cleveland WarlickChristopher View All Author Informationhttps://doi.org/10.1097/JU.0000000000002059.04AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: The management genitourinary (GU) malignancy in transplant recipients is challenging remains controversial, often based on historical practices that fail take into account recent progress both cancer diagnosis management, as well immunosuppression protocols used modern teams. Data regarding rates outcomes GU the solid organ (SOT) population lacking, studies exist small numbers patients. purpose study examine incidence, disease characteristics, clinical course bladder kidney diagnosed a large cohort. METHODS: University Minnesota SOT database, curated UNOS data collected from 1984–2019, was queried for who subsequently developed renal neoplasm. A retrospective chart review available electronic medical records performed results query obtain patient pathology, treatment, outcomes. RESULTS: In our cohort recipients, 42 patients were with cancer. High grade advanced (T2 or greater) present 27 (64.3%) 16 (38.1%) patients, respectively. Recurrences occurred 17 6 (35%) these being progression disease. Bladder cancer-related deaths 8 (19.1%). mean overall survival after initial 2.8 (±3.3) years. 111 neoplasm native kidney, whereas 33 graft kidney. majority masses localized treated radical nephrectomy. 2 surgery evidence metastasis, while 3 had metastasis presentation. CONCLUSIONS: Previously, we described cumulative incidence at Minnesota. Herein, broader characteristics which revealed those de novo their increased high compared commonly cited general population, case cell noted an rate diagnosis, but largely line population. Source Funding: None © 2021 American Urological Association Education Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e743-e743 Advertisement Copyright Permissions© Inc.MetricsAuthor Information Expand Loading ...